21st week of 2020 patent applcation highlights part 25 |
Patent application number | Title | Published |
20200157044 | PROCESS FOR RECOVERING ACETONITRILE FROM ACRYLONITRILE WASTE STREAMS | 2020-05-21 |
20200157045 | Process for preparing methionine | 2020-05-21 |
20200157046 | METHODS FOR FORMING PEROXYFORMIC ACID AND USES THEREOF | 2020-05-21 |
20200157047 | SULFOXYALKYL ORGANONITRO AND RELATED COMPOUNDS AND PHARMACEUTICAL COMPOUNDS FOR USE IN MEDICINE | 2020-05-21 |
20200157048 | (2E,4E)-5-PHENYL-PENTA-2,4-DIEN-1-ONE DERIVATIVE | 2020-05-21 |
20200157049 | QUATERNARY HETEROATOM CONTAINING COMPOUNDS | 2020-05-21 |
20200157050 | KCNQ2-5 CHANNEL ACTIVATOR | 2020-05-21 |
20200157051 | Pyridoxine Derivative for Treatment of Epilepsy | 2020-05-21 |
20200157052 | S1P3 Antagonists | 2020-05-21 |
20200157053 | Method of Treating or Inhibiting Malaria | 2020-05-21 |
20200157054 | METHOD FOR PREPARING PYRIMIDONE COMPOUND | 2020-05-21 |
20200157055 | Prolyl Hydroxylase Inhibitors | 2020-05-21 |
20200157056 | SELECTIVE SULFONATION OF BENZODIAZEPINE DERIVATIVES | 2020-05-21 |
20200157057 | PROCESSES FOR THE RESOLUTION OF BENZODIAZEPIN-2-ONE AND BENZOAZEPIN-2-ONE DERIVATIVES | 2020-05-21 |
20200157058 | METALLIC SALT CONTAINING ANION HAVING HETEROCYCLIC AROMATIC STRUCTURE, METHOD OF PREPARING THE METALLIC SALT, AND ELECTROLYTE AND ELECTROCHEMICAL DEVICE EACH INCLUDING THE METALLIC SALT | 2020-05-21 |
20200157059 | BENZOTRIAZOLE DERIVATIVE COMPOUND | 2020-05-21 |
20200157060 | FILM FORMING MATERIAL, COMPOSITION FOR FILM FORMATION FOR LITHOGRAPHY, MATERIAL FOR OPTICAL COMPONENT FORMATION, RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, PERMANENT FILM FOR RESIST, RADIATION-SENSITIVE COMPOSITION, METHOD FOR PRODUCING AMORPHOUS FILM, UNDERLAYER FILM FORMING MATERIAL FOR LITHOGRAPHY, COMPOSITION FOR UNDERLAYER FILM FORMATION FOR LITHOGRAPHY, METHOD FOR PRODUCING UNDERLAYER FILM FOR LITHOGRAPHY, AND CIRCUIT PATTERN FORMATION METHOD | 2020-05-21 |
20200157061 | CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(- 3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF | 2020-05-21 |
20200157062 | HETEROCYCLIC COMPOUND | 2020-05-21 |
20200157063 | Method for Preparation of Alkylated or Fluoro, Chloro and Fluorochloro Alkylated Compounds by Heterogeneous Cobalt Catalysis | 2020-05-21 |
20200157064 | Preparation of substituted 3-aryl-5-trifluoromethyl-1,2,4-oxadiazoles | 2020-05-21 |
20200157065 | CRYSTALLINE FORMS OF OZANIMOD AND OZANIMOD HYDROCHLORIDE, AND PROCESSES FOR PREPARATION THEREOF | 2020-05-21 |
20200157066 | Sulfonamide Compound or Salt Thereof | 2020-05-21 |
20200157067 | PROCESS FOR PREPARING 1,1,3-TRIOXO-1,2-BENZOTHIAZOLE-6-CARBOXAMIDE | 2020-05-21 |
20200157068 | BENZOTHIAZOLE AND RELATED COMPOUNDS | 2020-05-21 |
20200157069 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE | 2020-05-21 |
20200157070 | CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME | 2020-05-21 |
20200157071 | GREEN, COPPER-CATALYZED DISPROPORTIONATION OF AROMATIC AND HETEROAROMATIC CARBOXYLATES TO DICARBOXYLATES | 2020-05-21 |
20200157072 | NOVEL COMPOUNDS USEFUL AS POTASSIUM CHANNEL OPENERS | 2020-05-21 |
20200157073 | SUBSTITUTED N-ARYLETHYL-2-AMINOQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | 2020-05-21 |
20200157074 | PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | 2020-05-21 |
20200157075 | INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN | 2020-05-21 |
20200157076 | ACLY INHIBITORS AND USES THEREOF | 2020-05-21 |
20200157077 | HISTONE DEMETHYLASE INHIBITORS | 2020-05-21 |
20200157078 | NOVEL COMPOUNDS HAVING ESTROGEN RECEPTOR ALPHA DEGRADATION ACTIVITY AND USES THEREOF | 2020-05-21 |
20200157079 | IRE1 Small Molecule Inhibitors | 2020-05-21 |
20200157080 | CRYSTAL FORM OF DEUTERATED AZD9291, PREPARATION METHOD THEREFOR, AND USE THEREOF | 2020-05-21 |
20200157081 | COMPOUNDS, COMPOSITIONS AND METHODS | 2020-05-21 |
20200157082 | PHENYL INDOLE ALLOSTERIC INHIBITORS OF P97 ATPASE | 2020-05-21 |
20200157083 | COOLING COMPOSITION | 2020-05-21 |
20200157084 | INHIBITORS OF SOLUBLE ADENYLYL CYCLASE | 2020-05-21 |
20200157085 | MODULATORS OF HEMOGLOBIN | 2020-05-21 |
20200157086 | BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES | 2020-05-21 |
20200157087 | MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER | 2020-05-21 |
20200157088 | BENZENE FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | 2020-05-21 |
20200157089 | HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | 2020-05-21 |
20200157090 | NON-INVASIVE VENTILATION WITH HIGH FREQUENCY OSCILLATIONS | 2020-05-21 |
20200157091 | PYRROLO[2,3-C]PYRIDINES AND RELATED ANALOGS AS LSD-1 INHIBITORS | 2020-05-21 |
20200157092 | [1,2,4]-TRIAZOLO [1,5-A]-PYRIMIDINYL DERIVATIVES SUBSTITUTED WITH PIPERIDINE, MORPHOLINE OR PIPERAZINE AS OGA INHIBITORS | 2020-05-21 |
20200157093 | COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH | 2020-05-21 |
20200157094 | PD-1/PD-L1 INHIBITORS | 2020-05-21 |
20200157095 | APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF | 2020-05-21 |
20200157096 | NLRP3 MODULATORS | 2020-05-21 |
20200157097 | NLRP3 MODULATORS | 2020-05-21 |
20200157098 | 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS | 2020-05-21 |
20200157099 | 3,6,9, 15-TETRAAZA-BICYCLO [9.3.1 ]PENTADECA- 1(14), 11(15), 12-TRIENE BASED COMPOUNDS AND THEIR APPLICATION AS LIGANDS OF ESSENTIAL METAL ION BASED MRI AND 52MN BASED PET CONTRAST AGENTS | 2020-05-21 |
20200157100 | NOVEL SALTS AND CRYSTALS | 2020-05-21 |
20200157101 | REINFORCED MACROCYCLIC LIGANDS, COMPLEXES THEREOF, AND USES OF SAME | 2020-05-21 |
20200157102 | Methods for Preparing Bis-Tetrahydroisoquinoline-Containing Compounds | 2020-05-21 |
20200157103 | CRYSTALLINE FORMS OF SALTS OF FUSED TERA OR PENTA-CYCLIC DIHYDRODIAZEPINOCARAZOLONES, AND USES THEREOF | 2020-05-21 |
20200157104 | PYRIDO-IMIDAZO RIFAMYCINS | 2020-05-21 |
20200157105 | 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS | 2020-05-21 |
20200157106 | Novel Compounds and Uses Thereof | 2020-05-21 |
20200157107 | Compounds Useful as RET Inhibitors | 2020-05-21 |
20200157108 | METHODS OF MAKING AND USING PDE9 INHIBITORS | 2020-05-21 |
20200157109 | EFFICIENT PROCESS FOR THE PREPARATION OF SITAGLIPTIN THROUGH A VERY EFFECTIVE PREPARATION OF THE INTERMEDIATE 2,4,5-TRIFLUOROPHENYLACETIC ACID | 2020-05-21 |
20200157110 | 7-SITE SUBSTITUTED PYRROLE TRIAZINE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND PREPARATION METHOD THEREOF AND USES THEREOF | 2020-05-21 |
20200157111 | PIPERAZINE HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE OF SAME IN MEDICINE | 2020-05-21 |
20200157112 | 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE ANALOGS | 2020-05-21 |
20200157113 | PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS | 2020-05-21 |
20200157114 | OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE | 2020-05-21 |
20200157115 | Antiseptic Drug | 2020-05-21 |
20200157116 | LIBRARIES OF HETEROARYL-CONTAINING MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | 2020-05-21 |
20200157117 | 1-ARYLCARBONYL-4-OXY-PIPERIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2020-05-21 |
20200157118 | NOVEL POLYMORPHS OF DOLUTEGRAVIR AND SALTS THEREOF | 2020-05-21 |
20200157119 | MACROCYCLIC COMPOUNDS AND USES THEREOF | 2020-05-21 |
20200157120 | COMPOUNDS AND FILMS AND PHOTOELECTRIC DIODES AND ORGANIC SENSORS AND ELECTRONIC DEVICES | 2020-05-21 |
20200157121 | METHIONINE-METAL CHELATE AND MANUFACTURING METHOD THEREOF | 2020-05-21 |
20200157122 | BORON-CONTAINING DIACYLHYDRAZINES | 2020-05-21 |
20200157123 | PENICILLIN-BINDING PROTEIN INHIBITORS | 2020-05-21 |
20200157124 | LENS OIL HAVING A NARROW MOLECULAR WEIGHT DISTRIBUTION FOR INTRAOCULAR LENS DEVICES | 2020-05-21 |
20200157125 | Enhanced Perovskite Materials for Photovoltaic Devices | 2020-05-21 |
20200157126 | CARBONATE PRODRUGS AND METHODS OF USING THE SAME | 2020-05-21 |
20200157127 | Phospholipid Analogues | 2020-05-21 |
20200157128 | Process for preparing phosphorus-containing alpha-aminonitriles | 2020-05-21 |
20200157129 | IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | 2020-05-21 |
20200157130 | METHODS AND COMPOSITIONS FOR PREPARING NUCLEIC ACIDS THAT PRESERVE SPATIAL-PROXIMAL CONTIGUITY INFORMATION | 2020-05-21 |
20200157131 | METHOD FOR PRODUCING SWEETENER ALLULOSE | 2020-05-21 |
20200157132 | AMORPHOUS MIXTURE COMPRISING A NEUTRAL MONO- OR OLIGOSACCHARIDE AND AN ACIDIC NON-CARBOHYDRATE COMPONENT | 2020-05-21 |
20200157133 | WATER PROCESSES FOR PRODUCING POLYETHER POLYOLS FROM SOLID POLYHYDROXYL COMPOUNDS | 2020-05-21 |
20200157134 | E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | 2020-05-21 |
20200157135 | SIDE-CHAIN MODIFIED ERGOSTEROL AND STIGMASTEROL DERIVATIVES AS LIVER X RECEPTOR MODULATORS | 2020-05-21 |
20200157136 | Crystal Forms of -Nicotinamide Mononucleotide | 2020-05-21 |
20200157137 | 2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES | 2020-05-21 |
20200157138 | NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOGUES | 2020-05-21 |
20200157139 | CRYSTAL CHARACTERISTICS, PREPARATION PROCESSES AND ANTICANCER APPLICATIONS OF 17BETA-NERIIFOLIN CRYSTAL FORMS | 2020-05-21 |
20200157140 | NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS | 2020-05-21 |
20200157141 | METHODS DIRECTED TO CRYSTALLINE BIOMOLECULES | 2020-05-21 |
20200157142 | ULTRASOUND-ASSISTED SIMULATED DIGESTION METHOD OF MILK PROTEIN ACTIVE PEPTIDE AND APPLICATION THEREOF IN HEALTH FOODS | 2020-05-21 |
20200157143 | SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS | 2020-05-21 |